Severe Aplastic Anemia, Refractory
3 clinical trials · Condition
◉ Watch Severe Aplastic Anemia, Refractory
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes (NCT07712562) | Dren Bio | 2026-08-01 |
| Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA (NCT07299123) | Chinese PLA General Hospital | 2022-08-01 |
| Alemtuzumab to Treat Severe Aplastic Anemia (NCT00195624) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-09-15 |
Track Severe Aplastic Anemia, Refractory automatically
Every clearance here is in the API, with alerts when new ones post.